首页 / 院系成果 / 成果详情页

Tamarixetin protects against cardiac hypertrophy via inhibiting NFAT and AKT pathway  期刊论文  

  • 编号:
    50fd97a6-128c-48d6-acb3-db8865b9a351
  • 作者:
  • 语种:
    英文
  • 期刊:
    JOURNAL OF MOLECULAR HISTOLOGY ISSN:1567-2379 2019 年 50 卷 4 期 (343 - 354) ; AUG
  • 收录:
  • 关键词:
  • 摘要:

    Cardiac hypertrophy is a compensatory response in reaction to mechanical load that reduces wall stress by increasing wall thickness. Chronic hypertrophic remodeling involves cardiac dysfunction that will lead to heart failure and ultimately death. Studies have been carried out on cardiac hypertrophy for years, whereas the mechanisms have not been well defined. Tamarixetin (TAM), a natural flavonoid derivative of quercetin, have been demonstrated possessing anti-oxidative and anti-inflammatory effects on multiple diseases. However, little is known about the function of TAM on the development of cardiac hypertrophy. Here, we found TAM could alleviate pressure-overload-induced cardiac hypertrophy in transverse aortic constriction (TAC) mouse model, assessed by ventricular weight/body weight, lung weight/body weight, echocardiographic parameters, as well as myocyte cross-sectional area and the expression of ANP, BNP and Myh7. In vitro, TAM showed a dose dependent inhibitory effect on phenylephrine-induced hypertrophy in H9c2 cardiomyocytes. Furthermore, TAM reversed cardiac remodeling of stress overloaded heart by suppressing apoptosis and the expression of fibrotic-related genes, reduced oxidative stress and ROS production both in vivo and in vitro. In addition, TAM could negatively modulate TAC-induced nuclear translocation of NFAT and the activation of PI3K/AKT signaling pathways. Therefore, these data indicate for the first time that TAM has a protective effect on experimental cardiac hypertrophy and might be a novel candidate for the treatment of cardiac hypertrophy in clinic.

  • 推荐引用方式
    GB/T 7714:
    Fan Cheng,Li Yuan,Yang Hui, et al. Tamarixetin protects against cardiac hypertrophy via inhibiting NFAT and AKT pathway [J].JOURNAL OF MOLECULAR HISTOLOGY,2019,50(4):343-354.
  • APA:
    Fan Cheng,Li Yuan,Yang Hui,Cui Yuqian,&Guo Haipeng.(2019).Tamarixetin protects against cardiac hypertrophy via inhibiting NFAT and AKT pathway .JOURNAL OF MOLECULAR HISTOLOGY,50(4):343-354.
  • MLA:
    Fan Cheng, et al. "Tamarixetin protects against cardiac hypertrophy via inhibiting NFAT and AKT pathway" .JOURNAL OF MOLECULAR HISTOLOGY 50,4(2019):343-354.
  • 入库时间:
    1/9/2020 10:55:36 AM
  • 更新时间:
    1/9/2020 10:55:36 AM
  • 条目包含文件:
    文件类型: , 文件大小:
    正在加载全文
浏览次数:9 下载次数:0
浏览次数:9
下载次数:0
打印次数:0
浏览器支持: Google Chrome   火狐   360浏览器极速模式(8.0+极速模式) 
返回顶部